Results 61 to 70 of about 32,734 (287)

Safety of heterologous ChAdOx1-S/BNT162b2 primary schedule versus homologous BNT162b2 vaccination: Insights from an Italian post-marketing study, 2021

Human Vaccines & Immunotherapeutics, 2023
During COVID-19 vaccination campaign, possible ChAdOx1-S-associated risks of thrombosis with thrombocytopenia syndrome led to implement ChAdOx1-S/BNT162b2 heterologous vaccination, despite the limited information on its reactogenicity and safety.
Francesca Fortunato, Rosa Prato, Giuseppina Iannelli, Leonardo Ascatigno, Daniela Loconsole, Pier Luigi Lopalco, Domenico Martinelli   +6 more
doaj   +1 more source

Heterologous vaccination (ChAdOx1 and BNT162b2) induces a better immune response against the omicron variant than homologous vaccination

Journal of Infection and Public Health, 2023
Background: The ongoing COVID-19 pandemic has seen the emergence of numerous novel variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus.
Jaeeun Yoo, Younjeong Kim, Yu mi Cha, Jaewoong Lee, Yeon Jeong Jeong, Si-Hyun Kim, Lisa L. Maragakis, Seungok Lee   +7 more
doaj   +1 more source

Heterologous COVID-19 Booster Vaccination in the Chronic Disorder of Consciousness: A Pilot Study

Clinics and Practice, 2022
Significant anti-spike protein receptor-binding domain (S-RBD) antibody responses have been demonstrated in patients with chronic disorder of consciousness (DOC) completing a COVID-19 vaccine regime with BNT162b2 (Pfizer–BioNTech). We now provide further
Maria Elena Pugliese, Riccardo Battaglia, Maria Girolama Raso, Raffaela Chiaravalloti, Francesco Coschignano, Angela Pagliuso, Roberta Bruschetta, Giovanni Pugliese, Paolo Scola, Paolo Tonin, Antonio Cerasa   +10 more
doaj   +1 more source

Immunogenicity and Durability of Antibody Responses to Homologous and Heterologous Vaccinations with BNT162b2 and ChAdOx1 Vaccines for COVID-19

, 2022
During the COVID-19 pandemic, vaccines were developed based on various platform technologies and were approved for emergency use. However, the comparative analysis of immunogenicity and durability of vaccine-induced antibody responses depending on ...
Eui Ho Kim, Park, Soonju, Sun Min Lee, Kim, Paul, Lee, Seo Jin, Soonju Park, Kim, Eui Ho, Nakyung Lee, David Shum, Lee, Nakyung, Shum, David, Seo Jin Lee, Paul Kim, Kim, Dong Ho, Dong Ho Kim, Dong-In Kim, Lee, Sun Min, Kim, Dong-In   +17 more
core   +1 more source

The immunomodulatory effects of measles‐mumps‐rubella vaccination on persistence of heterologous vaccine responses [PDF]

Immunology & Cell Biology, 2019
AbstractIt is proposed that measles‐containing vaccines have immunomodulatory effects which include a reduction in all‐cause childhood mortality. The antibody response to heterologous vaccines provides a means to explore these immunomodulatory effects.
Petra Zimmermann, Kirsten P Perrett, Fiona RM van der Klis, Nigel Curtis   +3 more
openaire   +6 more sources

The Efficacy and Safety of Heterologous Immunization with Pfizer-BioNTech (Pfizer) to Individuals Who Have Completed A Primary Vaccination Schedule with Sinopharm (BBibp-CorV)

, 2023
The aim of this study was to examine the effectiveness and potential adverse reactions when providing a different Pfizer-BioNTech booster shot to 235 volunteers who had previously received the BBIBP-CorV Sinopharm primary vaccination series.
Mohammed Rashid Ameen, Warveen L. Abdulkareem, Nawfal R. Hussein, Narin A. Rasheed   +3 more
core   +1 more source

Choosing between Homologous or Heterologous COVID-19 Vaccination Regimens: A Cross-Sectional Study among the General Population in Italy [PDF]

, 2022
A shortage of COVID-19 vaccines and reports of side-effects led several countries to recommend a heterologous regimen for second vaccine doses. This study aimed to describe the reasons behind individuals’ choices of a homologous or a heterologous ...
Valerio Dimonte, Elena Casabona, Marco Clari, Albanesi, B., Rosanna Irene Comoretto, Alessio Conti, Godono, A., Dimonte, V., Clari, M., Alessandro Godono, Mansour, I., Casabona, E., Comoretto, R. I., Beatrice Albanesi, Ihab Mansour, Ciocan, C., Catalina Ciocan, Conti, A.   +17 more
core   +1 more source

Anti-SARS-CoV-2 spike IgG following injection of the third dose vaccine: A systematic review with meta-analysis of heterologous versus homologous vaccination

Frontiers in Public Health, 2023
BackgroundThe mass vaccination is a key strategy to prevent and control the coronavirus disease 2019 (COVID-19) pandemic. Today, several different types of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been developed ...
Mohammad-Shafi Mojadadi, Mohammad-Shafi Mojadadi, Seyed Alireza Javadinia, Fahimeh Attarian, Elham Samami, Elham Samami, Mona Sobhani   +6 more
doaj   +1 more source

The PPD-specific T-cell clonal response in UK and Malawian subjects following BCG vaccination: a new repertoire evolves over 12 months.

, 2006
Mycobacterium bovis bacille Calmette Guerin vaccination protects against pulmonary tuberculosis in the United Kingdom but not in Malawi. We investigated whether a difference in the clonal T-cell response to BCG vaccination might account for this.
Msiska, GK, Bennett, Andrea A., Fine, Paul E.M., de Lara, CM, Weir, Rosemary E., Ben-Smith, A, Msiska, Glyn K., Bennett, AR, Crampin, Amelia C, Beverley, Peter C.L., Fine, PE, Gorak-Stolinska, Patricia, Weir, RE, Bennett, Andrea R, Fine, Paul EM, Crampin, Amelia C., Ben-Smith, Anne, Lalor, MK, Dockrell, Hazel M., Floyd, Sian, Msiska, Glyn K, Beverley, Peter, de Lara, Catherine M, Beverley, Peter CL, Lalor, Maeve K., Makamo, K, Weir, Rosemary E, Crampin, AC, Gorak-Stolinska, P, Dockrell, HM, Beverley, PC, Lalor, Maeve K, Dockrell, Hazel M, de Lara, Catherine M., Makamo, Kandakuone, Floyd, S   +35 more
core   +1 more source

Mycobacterial purified protein derivatives stimulate innate immunity: Malawians show enhanced tumor necrosis factor alpha, interleukin-1beta (IL-1beta), and IL-10 responses compared to those of adolescents in the United Kingdom. [PDF]

, 2004
To investigate the role of innate immunity in variable efficacy of Mycobacterium bovis BCG vaccination in Malawi and the United Kingdom, we examined 24-h tumor necrosis factor alpha, interleukin-1beta (IL-1beta), and IL-10 responses to mycobacterial ...
Elizabeth King, King, Elizabeth, Jarman, Elizabeth, Hazel M. Dockrell, Lifted Sichali, Fine, Paul E.M., Blackwell, Jenefer M., Weir, Rosemary E., Elizabeth Jarman, Sally Stenson, Nazareth, Bernadette, Warndorff, David K., Crampin, Amelia C, Black, Gillian F, Stenson, Sally, Mwaungulu, Lorren, Amelia C. Crampin, Linda Donovan, Blackwell, Jenefer M, Rosemary E. Weir, Paul E. M. Fine, Sian Floyd, Bernadette Nazareth, Fine, Paul EM, David K. Warndorff, Black, Gillian F., Crampin, Amelia C., Dockrell, Hazel M., Jenefer M. Blackwell, Floyd, Sian, Chaguluka, Steven D, Lorren Mwaungulu, Sichali, Lifted, Donovan, Linda, Steven D. Chaguluka, Warndorff, David K, Weir, Rosemary E, Chaguluka, Steven D., Dockrell, Hazel M, Ngwira, Bagrey, Bagrey Ngwira, Gillian F. Black   +41 more
core   +1 more source